First Mercantile Trust’s Kite Pharma, Inc. KITE Stock Holding History

First Mercantile Trust’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,700	Closed	-$95K	–	925
2016 Q3	$95K	Buy	+1,700	New	+$94.7K	0.01%	731
2016 Q1	–	Sell	-1,195	Closed	-$74K	–	983
2015 Q4	$74K	Buy	+1,195	New	+$84.1K	0.01%	867

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

First Mercantile Trust's KITE Position: Q4 2016 in Review

First Mercantile Trust sold out of Kite Pharma, Inc. (KITE) in Q4 2016, closing a stake of 1,700 shares — an estimated $95K sold.

First Mercantile Trust first reported a position in KITE in Q4 2015 and held it in 2 quarters. The position peaked at $95K in Q3 2016. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

First Mercantile Trust reported no remaining Kite Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
First Mercantile Trust sold 1,700 Kite Pharma, Inc. shares in Q4 2016, an estimated $95K.
First Mercantile Trust first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 2 quarters.
First Mercantile Trust's Kite Pharma, Inc. position peaked at $95K in Q3 2016.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on First Mercantile Trust's 13F filing for Q4 2016, filed 10 Feb 2017.